Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Seattle, WA
SEC filing record 1 source field available
Fiscal year end
31 December
CTI BIOPHARMA CORP has filed 2,393 SEC EDGAR filings since 27 Jun 1996

SEC filing history

Showing 276-300 of 1,000 matching filings.

Per page
25
Current page
12
SC 13D/A File 005-48459

GROWTH EQUITY OPPORTUNITIES FUND V, LLC - CTI BIOPHARMA CORP.

Filing date
12 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Mar 2020
Reporting date
06 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-48459

AMENDMENT NO. 1

Filing date
10 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
09 Mar 2020
Reporting date
06 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Mar 2020
Reporting date
02 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
04 Mar 2020
Reporting date
02 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

AMENDMENT NO. 6 TO THE SCHEDULE 13D

Filing date
04 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-221382

424B5

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

FORM 8-K

Filing date
14 Feb 2020
Reporting date
14 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-48459

SC 13G/A filing

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

GROWTH EQUITY OPPORTUNITIES FUND V, LLC - CTI BIOPHARMA CORP. -- SCHEDULE 13D/A

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

AMENDMENT NO. 5 TO THE SCHEDULE 13D

Filing date
04 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
03 Feb 2020
Reporting date
03 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
03 Feb 2020
Reporting date
31 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
06 Dec 2019
Reporting date
03 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
15 Nov 2019
Reporting date
15 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-221382

424B5

Filing date
15 Nov 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
04 Nov 2019
Reporting date
31 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-12465

CT ORDER filing

Filing date
23 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
01 Oct 2019
Reporting date
01 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
01 Aug 2019
Reporting date
01 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
18 Jul 2019
Reporting date
18 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
04 Jun 2019
Reporting date
03 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .